3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow Triple Negative Breast Neoplasms: new trials by email Literature Review of Triple Negative Breast Neoplasms trials Research Report on Triple Negative Breast Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer Chemotherapeutic Agent - Triple Negative Breast Cancer | Phase 4 | Unknown | Fudan University | 60 | 2018-11-26 | 2019-01-10 |
| Huaier Granule in Treating Women With Triple Negative Breast Cancer Huaier Granule - Triple Negative Breast Cancer | Phase 4 | Unknown | Shandong University | 300 | 2015-10-01 | 2015-11-26 |
| Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer Toremifene; Anastrozole - Female Breast Cancer | Phase 4 | Unknown | Peking Union Medical College Hospital | 800 | 2014-11-01 | 2016-12-02 |
Breast Diseases (3) · Breast Neoplasms (3) · Neoplasms (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3)
Anastrozole (1) · Antineoplastic Agents (1) · Toremifene (1)
Fudan University (1) · Peking Union Medical College Hospital (1) · Shandong University (1)
China (3)
Zhimin Shao (1)